Reduced gray matter volume and respiratory dysfunction in Parkinson’s disease: a voxel-based morphometry study

BackgroundThe respiratory dysfunction of patients with Parkinson’s disease (PD) has drawn increasing attention. This study evaluated the relationship between gray matter volume (GMV), as determined by voxel-based morphometry (VBM), and respiratory dysfunction in patients with PD and correlated it with systemic inflammatory markers.MethodsWhole-brain VBM analysis was performed on 3-dimensional T1-weighted images in 25 PD patients with abnormal pulmonary function (13 men, 12 women; mean age: 62.9 ± 10.8 years) and, for comparison, on 25 sex- and age-matched PD patients with normal pulmonary function (14 men, 11 women; mean age: 62.3 ± 6.9 years). Inflammatory markers were determined by flow cytometry. The differences and correlations in regional GMV, clinical severity and inflammatory markers were determined after adjusting for age, gender and total intracranial volume (TIV).ResultsCompared with the normal pulmonary function group, the abnormal pulmonary function group had smaller GMV in several brain regions, including the left parahippocampal formation, right fusiform gyrus, right cerebellum crus, and left postcentral gyri. Forced expiratory volume in 1 s (FEV1) and maximal expiratory flow after expiration of 50% of forced vital capacity (MEF50) were positively correlated with regional GMV. There were no significant differences in the level of serum inflammatory markers between two groups.ConclusionOur findings suggested that involvement of the central autonomic network and GM loss may underlie the respiratory dysfunction in PD patients.

[1]  V. Napadow,et al.  The Autonomic Brain: An Activation Likelihood Estimation Meta-Analysis for Central Processing of Autonomic Function , 2013, The Journal of Neuroscience.

[2]  Cheng-Hsien Lu,et al.  Increased circulating endothelial progenitor cells and anti-oxidant capacity in obstructive sleep apnea after surgical treatment. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[3]  D. Jacobs,et al.  Association of circulating adhesion molecules with lung function. The CARDIA study. , 2009, Chest.

[4]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[5]  R. Djaldetti,et al.  Respiratory distress: an unrecognized non-motor phenomenon in patients with parkinsonism , 2011, Journal of neural transmission.

[6]  Cheng-Hsien Lu,et al.  Level and Value of Circulating Endothelial Progenitor Cells in Patients After Acute Ischemic Stroke , 2008, Stroke.

[7]  Manuel Rodriguez,et al.  Obstructive and restrictive pulmonary dysfunctions in Parkinson's disease , 1996, Journal of the Neurological Sciences.

[8]  M. Peters,et al.  Abnormal ventilatory control in Parkinson's disease—Further evidence for non-motor dysfunction , 2011, Respiratory Physiology & Neurobiology.

[9]  John Ashburner,et al.  A fast diffeomorphic image registration algorithm , 2007, NeuroImage.

[10]  J. Widdicombe,et al.  The autonomic nervous system and breathing. , 1970, Archives of internal medicine.

[11]  L M Parsons,et al.  Neuroimaging evidence implicating cerebellum in the experience of hypercapnia and hunger for air. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Y. Tsai,et al.  Mapping gray matter reductions in obstructive sleep apnea: an activation likelihood estimation meta-analysis. , 2014, Sleep.

[13]  A. Mangoni,et al.  Plasma protein thiols: an early marker of oxidative stress in asthma and chronic obstructive pulmonary disease , 2016, European journal of clinical investigation.

[14]  G. Viegi,et al.  Coming together: the ATS/ERS consensus on clinical pulmonary function testing , 2005, European Respiratory Journal.

[15]  Cheng-Hsien Lu,et al.  Association Between Autonomic Impairment and Structural Deficit in Parkinson Disease , 2016, Medicine.

[16]  Jiaxing Zhang,et al.  Reduced Regional Gray Matter Volume in Patients with Chronic Obstructive Pulmonary Disease: A Voxel-Based Morphometry Study , 2013, American Journal of Neuroradiology.

[17]  J. Hankinson,et al.  SERIES ''ATS/ERS TASK FORCE: STANDARDISATION OF LUNG FUNCTION TESTING'' Edited by V. Brusasco, R. Crapo and G. Viegi Number 3 in this Series Standardisation of the measurement of lung volumes , 2005 .

[18]  T. Chao,et al.  The Use of Benzodiazepine Receptor Agonists and Risk of Respiratory Failure in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Case-Control Study. , 2015, Sleep.

[19]  Cheng-Hsien Lu,et al.  The association between serum adhesion molecules and outcome in acute spontaneous intracerebral hemorrhage , 2011, Critical care.

[20]  Jing Feng,et al.  Obstructive sleep apnea and endothelial progenitor cells , 2013, Patient preference and adherence.

[21]  J. Obeso,et al.  Pathophysiology of the basal ganglia in Parkinson's disease , 2000, Trends in Neurosciences.

[22]  Ching-Po Lin,et al.  White matter damage and systemic inflammation in obstructive sleep apnea. , 2015, Sleep.

[23]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.

[24]  J. D. Watson,et al.  Evidence for limbic system activation during CO2‐stimulated breathing in man. , 1995, The Journal of physiology.

[25]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[26]  Andreas Hald,et al.  Oxidative stress and inflammation in Parkinson's disease: is there a causal link? , 2005, Experimental Neurology.

[27]  G. Viegi,et al.  Standardisation of the measurement of lung volumes , 2005, European Respiratory Journal.

[28]  K. Evans.  Cortico-limbic circuitry and the airways: Insights from functional neuroimaging of respiratory afferents and efferents , 2010, Biological Psychology.

[29]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[30]  A. Takakura,et al.  Respiratory deficits in a rat model of Parkinson’s disease , 2015, Neuroscience.

[31]  S. Lehéricy,et al.  Medulla oblongata damage and cardiac autonomic dysfunction in Parkinson disease , 2016, Neurology.

[32]  E. Benarroch.  The central autonomic network: functional organization, dysfunction, and perspective. , 1993, Mayo Clinic proceedings.

[33]  F. Rutten,et al.  Diagnostic and prognostic utility of mid-expiratory flow rate in older community-dwelling persons with respiratory symptoms, but without chronic obstructive pulmonary disease , 2015, BMC Pulmonary Medicine.